CompletedNCT06698588
Symptom-specific Effects of Omega-3 Across Neurodevelopmental Symptoms
Placebo researchAges 5–12United KingdomADHD
Understand this study
Who was this study for?
Listed age limits: 5 years to 12 years.
- Listed locations
- SwanseaSee all locations and recruitment
Study information
Study start dateStarted: November 7, 2024
- Recruitment status
- Completed
- Enrollment listed in the registry
- 200
- Sponsor
- Swansea University
- Sponsor type
- University
- Study type
- Other
- Intervention type
- DIETARY_SUPPLEMENT
- Study phase
- Not clearly listed
- Locations
- United Kingdom
- Age range
- From 5 Years to 12 Years
- Official registry ID
- NCT06698588
- Official title
Show the full official title
Examining Symptom-Specific Effects of Omega-3 Fatty Acids in Children With ADHD / ASD Symptoms and Sleep Problems: A Network Approach.
Get this study by email
Recruitment & locations
CompletedSwansea
Questions about this study
Who is behind this study?
The study sponsor is Swansea University, a university.
Who was this study for?
Listed age limits: 5 years to 12 years.
